VitaRNA is projected to decline to $0.438 by 2027, a -21% move from its current price of $0.5549. VITARNA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.5049 | $0.5541 | $0.6081 | -0.13% |
| May 30 | $0.4852 | $0.5534 | $0.6311 | -0.27% |
| May 31 | $0.4704 | $0.5526 | $0.6492 | -0.40% |
| Jun 1 | $0.4582 | $0.5519 | $0.6647 | -0.54% |
| Jun 2 | $0.4477 | $0.5511 | $0.6785 | -0.67% |
| Jun 3 | $0.4383 | $0.5504 | $0.6912 | -0.81% |
| Jun 4 | $0.4298 | $0.5496 | $0.7029 | -0.94% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4298 | $0.5496 | $0.7029 | -0.94% |
| Week 2 | $0.3845 | $0.5445 | $0.771 | -1.87% |
| Week 3 | $0.3522 | $0.5394 | $0.8259 | -2.79% |
| Week 4 | $0.3267 | $0.5343 | $0.8739 | -3.70% |
| Week 5 | $0.3054 | $0.5293 | $0.9174 | -4.61% |
| Week 6 | $0.287 | $0.5243 | $0.9578 | -5.51% |
| Week 7 | $0.2709 | $0.5194 | $0.9957 | -6.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
VitaRNA is a token tied to a gene therapy project described as the tokenization of the Artan Bio IP-NFT by VitaDAO.
It sits within the Ethereum Ecosystem and Decentralized Science (DeSci) categories, positioning it in a space that blends biotech IP with decentralized infrastructure.
VitaRNA (VITARNA) is trading at $0.5549 and holds a market capitalization of $1.31M, ranking 2758 by market cap. These figures place VitaRNA among a broad set of small-cap crypto assets with targeted biotech and DeSci focus.
The asset has recorded all-time highs at $7.46 and all-time lows at $0.1498, illustrating substantial historical volatility within its trading range. The forecasted outlook shows a long-term trajectory that begins near the current price in 2026, with notable upside potential later in the period. The 2026 average is $0.5549, expanding to a 2050 average of $10.93 with a max forecast of $25.15, reflecting wide potential movement across the horizon.
A major floor 72.6% below — a decisive break under it would weaken the trend.
The nearest floor, 37.7% below — buyers have tended to step in here.
The nearest ceiling, 127.7% above — a clean break opens room to run.
A major ceiling 195.4% above — clearing it would confirm fresh momentum.
Key VITARNA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VITARNA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.5763 | Sell | $0.577 | Sell |
| MA 10 | $0.6027 | Sell | $0.6111 | Sell |
| MA 20 | $0.7027 | Sell | $0.6383 | Sell |
| MA 50 | $0.5235 | Buy | $0.553 | Buy |
| MA 100 | $0.3526 | Buy | $0.47 | Buy |
| MA 200 | $0.3922 | Buy | $0.542 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.40 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -98.52 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -24.49 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.77 | Buy |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 30.31 | Neutral |
| Momentum (10) | -0.15 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 0.56 | Sell |
| ADX (14) | 18.74 | Neutral |
| ATR (14) | 0.05 | Info |
The near-term technical picture is bullish overall as reflected by the sentiment rating and price action indicators. RSI14 sits at 40, with the price currently hovering around the SMA50 of $0.5235 and above the SMA200 of $0.3922, suggesting some upward slack before resistance.
Support is identified at $0.3455 and resistance at $1.26, framing a shallow upside path in the immediate term. The 30-day trading range spans from $0.3334 to $0.9233, underscoring the recent price volatility within a relatively tight corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.1519 | $0.5549 | $0.7656 | 0% | Neutral | |
| $0.3149 | $0.438 | $0.6592 | -21% | Bearish | |
| $0.2569 | $0.3792 | $0.6069 | -32% | Bearish | |
| $0.9262 | $1.44 | $2.42 | +159% | Bullish | |
| $0.8392 | $1.37 | $2.39 | +146% | Bullish | |
| $0.4362 | $0.7424 | $1.34 | +34% | Bullish | |
| $0.6367 | $1.13 | $2.10 | +104% | Bullish | |
| $1.21 | $2.24 | $4.28 | +304% | Bullish | |
| $1.36 | $2.62 | $5.13 | +371% | Bullish | |
| $1.16 | $2.32 | $4.65 | +318% | Bullish | |
| $1.11 | $2.46 | $5.42 | +343% | Bullish | |
| $4.92 | $10.93 | $25.15 | +18.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.1519 | $0.5549 | $0.6708 | +0.00% |
| June 2026 | $0.4508 | $0.5414 | $0.6743 | -2.42% |
| July 2026 | $0.4018 | $0.4907 | $0.6264 | -9.38% |
| August 2026 | $0.4341 | $0.5371 | $0.6988 | +9.46% |
| September 2026 | $0.4717 | $0.59 | $0.7797 | +9.86% |
| October 2026 | $0.432 | $0.546 | $0.7316 | -7.46% |
| November 2026 | $0.4066 | $0.5186 | $0.7032 | -5.03% |
| December 2026 | $0.4339 | $0.5582 | $0.7656 | +7.64% |
Click any year to see its month-by-month VITARNA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VITARNA price prediction for 2026 points to an average of $0.5549 (low $0.1519, high $0.7656) — a potential gain of 0% on today's $0.5549. Price action looks broadly range-bound.
In 2027, VITARNA is projected to trade between $0.3149 and $0.6592, averaging $0.438 — a potential decline of -21% from today's $0.5549. That is -21% versus the projected 2026 average. Expect choppier, lower action through this leg of the cycle.
VitaRNA's 2028 outlook centres on $0.3792, within a $0.2569 to $0.6069 range. That is -13% versus the projected 2027 average. That marks a -32% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2029, VITARNA could reach as high as $2.42, with a base case around $1.44 and support toward $0.9262 — roughly +159% from $0.5549. Buyers look set to stay in control over this stretch.
Expect VITARNA to range from $0.8392 to $2.39 through 2030. The $1.37 average target implies a +146% move from current prices. That is -5% versus the projected 2029 average. Momentum favours further upside here.
The VITARNA price prediction for 2031 points to an average of $0.7424 (low $0.4362, high $1.34) — a potential gain of +34% on today's $0.5549. Buyers look set to stay in control over this stretch.
In 2032, VITARNA is projected to trade between $0.6367 and $2.10, averaging $1.13 — a potential gain of +104% from today's $0.5549. That is up +52% on the projected 2031 average. Momentum favours further upside here.
VitaRNA's 2033 outlook centres on $2.24, within a $1.21 to $4.28 range. That is up +98% on the projected 2032 average. That marks a +304% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, VITARNA could reach as high as $5.13, with a base case around $2.62 and support toward $1.36 — roughly +371% from $0.5549. Momentum favours further upside here.
Expect VITARNA to range from $1.16 to $4.65 through 2035. The $2.32 average target implies a +318% move from current prices. That is -11% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The VITARNA price prediction for 2040 points to an average of $2.46 (low $1.11, high $5.42) — a potential gain of +343% on today's $0.5549. Momentum favours further upside here.
In 2050, VITARNA is projected to trade between $4.92 and $25.15, averaging $10.93 — a potential gain of +18.7x from today's $0.5549. That is up +345% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in VITARNA today (≈ 1,802.275914 VITARNA) could be worth
$19,707.39
+$18,707.39 (+1871%) by 2050 · US Dollar
Based on the average projected VITARNA price of $10.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VITARNAwould be worth at today's price.
$1,000 invested in VITARNA on May 26, 2025 (≈ 606.497462 VITARNA) would be worth
$336.52
-$663.48 (-66.3%) today · 0.34× · US Dollar
Based on a VITARNA entry price of $1.65 vs. today's $0.554854.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.638978 | $868.35 | -13.2% |
| 1 month ago | $0.357131 | $1,553.64 | +55.4% |
| 3 months ago | $0.182471 | $3,040.77 | +204.1% |
| 6 months ago | $0.517236 | $1,072.73 | +7.3% |
| 1 year ago | $1.65 | $336.52 | -66.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VITARNA forecast.
Our base-case forecast reaches $1.10 around 2029.
Implied market cap at $1.10: $2.6M
The multi-year forecast shows a mixed start but strong long-run upside. In 2026 the min, avg, and max are $0.1519, $0.5549, and $0.7656, respectively, with a neutral sentiment. The years 2027 and 2028 are bearish on average, with 2027 at $0.438 (min $0.3149, max $0.6592) and ROI -21.1, and 2028 at $0.3792 (min $0.2569, max $0.6069) with ROI -31.6.
From 2029 onward the outlook turns bullish, with 2029 averaging $1.44 and ROI 159.4, and 2030 averaging $1.37 with ROI 146.3. The momentum continues through 2031 ($0.7424 avg), 2032 ($1.13 avg), 2033 ($2.24 avg, ROI 303.7), 2034 ($2.62 avg, ROI 371.4), and 2035 ($2.32 avg, ROI 317.8).
The forecast extends to 2040 with an average of $2.46 and ROI 343.2, and to 2050 with an average of $10.93 and a max of $25.15, ROI 1870.7. Across these years, the sentiment remains BULLISH in the later horizon, highlighting substantial upside potential albeit with notable variability and risk in earlier years.
Tap a question to reveal the answer.
2030: min $0.8392, avg $1.37, max $2.39; ROI 146.3; sentiment BULLISH.
The forecast shows a mixed start with neutral in 2026, bearish in 2027-2028, and bullish long term. Notably, 2029 onward projects substantial upside, with 2050 averaging $10.93 and a max of $25.15, though there are periods of downside risk in earlier years.
Yes, the forecast includes a max of $5.13 in 2034, with earlier years peaking at $4.28 in 2033 and $4.65 in 2035; the long-run max is $25.15 in 2050.
Current price is $0.5549 and market cap is $1.31M.
The 30-day range is $0.3334 to $0.9233.
VitaRNA Community Discussion
0Share your VitaRNA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.